A patient-centered approach is recommended to tailor to individual needs when calculating individual protein needs.
In the CONVERT trial 830 maintenance renal allograft recipients (6–120 months post-transplant ... 20–40 ml/min and in patients with baseline proteinuria. Worsening proteinuria among patients ...
LYSOZYME, a bacteriolytic enzyme discovered in 1922 by Sir Alexander Fleming, 2 is found in a number of biologic fluids. The enzyme is a basic protein of low molecular weight that lyses ...
We are excited to announce the initiation of our HORIZON Study for MZE829, a Phase 2 clinical trial with a novel, potential new medicine that could disrupt current treatment for AKD,” said Harold ...
Albuminuria and proteinuria predict increased risk of cardiovascular and renal end points in patients with diabetic or nondiabetic kidney disease. [40,41] Clinical trials have found that reduction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results